A5013018244- Bladder and Urothelial Cancer Treatments
- Prostate Cancer Treatment and Research
- Renal cell carcinoma treatment
- Prostate Cancer Diagnosis and Treatment
- Urinary and Genital Oncology Studies
- Urological Disorders and Treatments
- Urinary Bladder and Prostate Research
- Sexual function and dysfunction studies
- Renal and related cancers
- Hormonal and reproductive studies
- Multiple and Secondary Primary Cancers
- Urologic and reproductive health conditions
- Minimally Invasive Surgical Techniques
- Genital Health and Disease
- Pediatric Urology and Nephrology Studies
- Cancer Genomics and Diagnostics
- Prenatal Screening and Diagnostics
- Sexual Differentiation and Disorders
- Testicular diseases and treatments
- Cancer, Lipids, and Metabolism
- Epigenetics and DNA Methylation
- Multiple Myeloma Research and Treatments
- Cancer Treatment and Pharmacology
- Esophageal Cancer Research and Treatment
- Renal and Vascular Pathologies
University of Molise
2023-2025
Consorzio Milano Ricerche
2025
Humanitas Gavazzeni
2018-2024
Federico II University Hospital
2003-2022
University of Salerno
2012-2021
Ospedali Riuniti San Giovanni di Dio e Ruggi d'Aragona
2015-2021
Istituto Ortopedico Gaetano Pini
2020
University of Messina
2020
Azienda Ospedaliera Bolognini Seriate
2017
University of Bari Aldo Moro
2015
The objective of the current study was to compare, in a large multicenter study, discriminating accuracy four prognostic models developed predict survival patients undergoing nephrectomy for nonmetastatic renal cell carcinoma (RCC).A total 2404 records from 6 European centers were retrospectively reviewed. For each patient, scores calculated according models: Kattan model, University California at Los Angeles integrated staging system (UISS) Yaycioglu and Cindolo model. Survival curves...
Authors from Naples, Paris and Rennes describe their efforts to develop a model for the preoperative prediction of outcome non‐metastatic renal cancer. It is valuable both urologist patient such model, particularly so on criteria. The results study are interesting, leading possibly helpful findings. In another article, authors Iceland estimated risk developing prostate other cancer among relatives men that country diagnosed with They found family history factor cancer, potentially higher...
Abstract BACKGROUND The current study validated the 2002 edition of TNM staging system in a multicenter, multinational European series localized renal cell carcinoma (RCC). METHODS authors analyzed clinical data 2217 patients who had undergone radical or partial nephrectomy for RCC 7 urologic centers. RESULTS In study, 1065 (48%) were classified as having pT1a disease, 771 (34.8%) pT1b and 381 (17.2%) pT2 disease. Tumor histotype was conventional 1886 (85%), papillary 182 (8.2%) patients,...
To determine the activity and tolerability of docetaxel re-treatment after first-line therapy with in castration-resistant prostate cancer (CRPC).Between November 2005 January 2009, 45 patients initially responding to then experiencing disease progression a period biochemical remission at least 5 months were enrolled prospective multicenter study re-treated docetaxel. The primary endpoint was response (biochemical partial defined as > 50% prostate-specific antigen [PSA] decline); secondary...
Abstract BACKGROUND Prostate health index (phi) and prostate cancer antigen 3 (PCA3) have been recently proposed as novel biomarkers for (PCa). We assessed the diagnostic performance of these biomarkers, alone or in combination, men undergoing first biopsy suspicion PCa. METHODS One hundred sixty male subjects were enrolled this prospective observational study. PSA molecular forms, phi (Beckman coulter immunoassay), PCA3 score (Progensa assay), other established (tPSA, fPSA, %fPSA) before...
Recently, many studies explored the role of inflammation parameters in prognosis urinary cancers, but results were not consistent. The modified Glasgow Prognostic Score (mGPS), a systemic marker, is prognostic marker various types cancers. aim present study was to investigate usefulness preoperative mGPS as predictor recurrence-free (RFS), overall (OS), and cancer-specific (CSS) survivals large cohort urothelial bladder cancer (UBC) patients. A total 1037 patients with UBC included this...
Objective To describe the trend in surgical volume urology Italy during coronavirus disease 2019 (COVID-19) outbreak, as a result of abrupt reorganisation Italian national health system to augment care provision symptomatic patients with COVID-19. Methods A total 33 urological units physicians affiliated AGILE consortium (Italian Group for Advanced Laparo-Endoscopic Surgery; www.agilegroup.it) were surveyed. Urologists asked report amount elective procedures week-by-week, from beginning...
<b><i>Purpose:</i></b> The coronavirus disease 2019 (COVID-19) pandemic has put a substantial burden on the Italian healthcare system, resulting in restructuring of hospitals to care for COVID-19 patients. However, this likely impacted access patients experiencing other conditions. We aimed quantify impact with urgent/emergent urological conditions throughout Italy. <b><i>Materials and Methods:</i></b> A questionnaire was sent 33 units AGILE...
To investigate the health-related quality of life uro-oncologic patients whose surgery was postponed without being rescheduled during coronavirus disease 2019 (COVID-19) pandemic.From March 1 to April 26, 2020, major urologic surgeries were drastically reduced at our tertiary-care referral hospital. In order evaluate quality-of-life outcomes, SF-36 questionnaire sent all scheduled for department 3 weeks after cancellation planned surgical procedures because COVID-19 emergency.All included in...
Abstract Purpose To detect any choroidal thickness (CT) change in patients after alpha-lytic drugs withdrawal that could help the cataract surgery timing decision. Methods Twenty-five eyes of 25 (mean age: 76 ± 7 years) under therapy, and control subjects (CS) 75 without both scheduled for fellow eye, were included this observational, prospective, non-randomized study. All underwent EDI-OCT during first preoperative visit approximately 1 month (range 28–31 days) withdrawal. In CS group, OCT...
Galectin-1 and galectin-3 are galactoside-binding proteins involved in different steps of tumor progression potential targets for therapy. We have investigated the expression these galectins 38 human bladder transitional-cell carcinomas histological grade clinical stage 5 normal urothelium samples. mRNA levels were highly increased most high-grade tumors compared with or low-grade tumors. Western blot immuno-histochemical analysis neoplastic tissues revealed a higher content galectin-1...
Abstract BACKGROUND The current study defined an optimal tumor size breakpoint to stratify localized renal cell carcinoma (RCC) into groups with significantly different cancer‐related outcomes and proposed a revision of the TNM classification system. METHODS authors analyzed data from 1138 patients who had undergone partial or radical nephrectomy for RCC at 7 European urologic centers. pathologic was calculated using martingale residuals Cox proportional hazards regression model. RESULTS...
No AccessJournal of UrologyAdult urology1 Jul 2007Prognostic Impact Tumor Size on pT2 Renal Cell Carcinoma: An International Multicenter Experience Tobias Klatte, Jean-Jacques Patard, Rakhee H. Goel, Mark D. Kleid, Francois Guille, Bernard Lobel, Clement-Claude Abbou, Alexandre De La Taille, Jacques Tostain, Luca Cindolo, Vincenzo Altieri, Ficarra, Walter Artibani, Tommaso Prayer-Galetti, Ernst Peter Allhoff, Luigi Schips, Richard Zigeuner, Robert A. Figlin, Fairooz F. Kabbinavar, Allan J....
Abstract Background Aim of this study was to evaluate and compare perioperative outcomes transperitoneal (TP) retroperitoneal (TR) approaches in a multi-institutional cohort minimally invasive partial nephrectomy (MI-PN). Material methods All consecutive patients undergone MI-PN for clinical T1 renal tumors at 26 Italian centers (RECORd2 project) between 01/2013 12/2016 were evaluated, collecting the pre-, intra-, postoperative data. The then stratified according surgical approach, TP or RP....
Prostate cancer (PCa) is one of the most prevalent cancers in world. Standard methods screening and diagnosis for prostate have been effective but can result overtreatment indolent cancer, leading to increased morbidity. Multiparametric magnetic resonance imaging (MRI) fusion biopsy are tools achieve better diagnostic accuracy. A combination multiparametric MRI photodynamic therapy be used as an alternative active surveillance low-risk detect disease progression while avoiding overtreatment....